EP3006032A1 — The use of solid carrier particles to improve the processability of a pharmaceutical agent
Assigned to Gilead Sciences Inc · Expires 2016-04-13 · 10y expired
What this patent protects
The invention provides a composition or a tablet comprising a compound of formula (I) or a pharmaceutically acceptable salt thereof and a plurality of solid carrier particles, preferably silica particles, as well as a method for providing a mixture with said compound and particle…
USPTO Abstract
The invention provides a composition or a tablet comprising a compound of formula (I) or a pharmaceutically acceptable salt thereof and a plurality of solid carrier particles, preferably silica particles, as well as a method for providing a mixture with said compound and particles. The compound of formula (I) inhibits the activity of cytochrome P-450.
Drugs covered by this patent
- Tybost (COBICISTAT) · Gilead Sciences
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.